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Smad4 critically mediate TGF-β-stimulated TIMP-3 gene expres-
sion in human chondrocytes and TIMP-3 gene is a target of
Smad signaling pathway. Most of the TGF-β-responsive, cis-
acting elements are found in the -167 with additional elements
in upstream fragments.These mechanisms of TIMP-3 regulation
may be pivotal in TGF-β-stimulated cartilage ECM synthesis,
repair and maintenance.
157
THE THROMBOSPONDIN-RELATED PROTEIN,
F-SPONDIN, IS EXPRESSED IN EMBRYONIC GROWTH
PLATE CARTILAGE AND CAN ENHANCE THE
EXPRESSION OF CHONDROCYTE MATURATION
MARKERS
G. Palmer, M. Attur, Y. Nemelivsky, A. Piton, H. Al-Mussawir,
S.B. Abramson, C. Teixeira
NYU-Hospital for Joint Diseases, New York, NY
Purpose: We have previously identiﬁed expression of a neuronal
extracellular matrix protein, F-spondin, in cartilage of osteoarthri-
tis (OA) patients. Since OA chondrocytes have been shown
express markers associated with growth plate chondrocyte mat-
uration, we explored whether F-spondin is also expressed in
growth plates during development.
Methods: For cell culture experiments, chondrocytes were iso-
lated from the cephalic portion of 2-week old embryonic chick
sterna. At conﬂuence, cultures were treated with retinoic acid
(RA) to induce maturation, or left unstimulated for 5 days. In
some experiments, F-spondin effects were assessed by plasmid
transfection (GenePorter) or treatment with blocking antibodies.
Chondrocyte maturation was assessed by measurement alkaline
phosphatase (AP) enzyme activity, or semi-quantitative RT-PCR
of chondrogenic markers.
Results: Immunohistochemistry of tibial growth plate cartilage
from 18 day old chick embryos revealed abundant staining for
F-spondin within the hypertrophic and ossifying regions, but no
staining in the immature chondrocytes of the resting and pro-
liferating zones. This expression pattern implicates a role for
F-spondin in late-stage terminal differentiation. To investigate the
role of F-spondin in chondrocyte maturation, we used an in vitro
model in which chick sternal chondrocytes mimic growth plate
chondrocytes and undergo terminal differentiation in response
to RA treatment. RA stimulation for 5 days (10 - 100 nm) re-
sulted in a 2- to 4-fold increase in F-spondin gene expression
when compared to non-stimulated controls. Overexpression of
F-spondin cDNA by plasmid transfection, increased expression
of chondrocyte terminal differentiation markers, MMP-13 (5-fold)
and alkaline phosphatase (AP) (14-fold) in cultures stimulated
with RA (p<0.05). However, this effect was not observed in F-
spondin transfected cultures without RA stimulation, suggesting
that F-spondin acts as an enhancer rather than an inducer of
terminal differentiation. Consistent with these ﬁndings, blocking
F-spondin activity via addition of polyclonal F-spondin antibodies
resulted in an inhibition of RA-induced chondrocyte maturation,
evidenced by decreased AP activity. The level of inhibition was
dependent on the antibody speciﬁcity to F-spondin protein do-
mains; blocking the c-terminal, thrombospondin-like TSR domain
caused a 50% (p<0.01) inhibition of AP activity, while targeting
the n-terminal, spondin domain reduced this effect to 2-10%.
This ﬁnding suggests that F-spondin induction of AP during
chondrocyte maturation is mediated via its TSR domain.
Conclusions: F-spondin is expressed in the developing growth
plate where it acts to enhance terminal differentiation of chondro-
cytes via upregulation of hypertrophic markers. These promat-
uration effects are mediated via novel mechanisms that require
molecular interactions of its protein domains.
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SUSTAINED EFFECTS OF BIOMECHANICAL SIGNALS
ARE MEDIATED VIA PROLONGED INHIBITION OF
I-KAPPA B KINASE ACTIVATION IN ARTICULAR
CHONDROCYTES
S. Madhavan, J. Nam, B. Rath, S. Agarwal
The Ohio State University, Columbus, OH
Purpose: While it is believed that the effects of therapeutic
exercise are sustained for sustained periods of time, te molecular
mechanisms underlying such effects are less understood. Here,
using an in vitro model system, we show that biomechanical
signals suppress inﬂammation for sustained intervals of time and
these effects are mediated by inhibiting NF-κB signaling pathway.
Methods: Articular chondrocytes were harvested from healthy
femur heads of Sprague Dawley rats and used between 2nd and
3rd passages. Dynamic tensile strain (DTF) was applied to chon-
drocytes grown on BioFlex-I® plates using a FX-4000T Flexcell
Int, NC). Cells were subjected to (A) control, (B) IL-1β 1ng/ml
(C) DTF (3% strain at 0.25 Hz), or (D) DTF and IL-1β. Cells
in groups C and D were subjected to DTF at the start of the
experiment, and rHuIL-1β was immediately added to groups B
and D. The cells were subject to DTF for 4, 8, 12, 16, 20 or 24 hr,
followed by a rest period of 20, 16, 12, 8, 4, or 0 h, respectively.
mRNA expression was measured by Real Time PCR. TNF-α
secretion was determined with ELISA kit (R&D Systems). The
nuclear translocation of NF-κB p65 and IκBα was analyzed by
immunoﬂuorescence. Protein expression was analyzed by West-
ern blot analysis using mouse anti-pNF-κB(Ser 536 or Ser 276),
rabbit anti-p65 IgG, rabbit anti-IκBα IgG and rabbit anti-IκBβ IgG.
Kinetics of IKK activation was by a kinase assay using GST-IκBα
and 0.5um ATP. The GST-IκBα on blots was probed with either
anti-phospho-IκBα (Ser32/36) or anti-IκBα.
Results: (1) DTF blocks IL-1β-induced TNFα induction at both
mRNA and protein level in a sustained manner. (2) DTF inhibits
phosphorylation, nuclear translocation, and synthesis of NF-κB
in a sustained manner. DTF also sustained suppression of IL-
1β-induced NF-κB p65 phosphorylation at Ser 536 (Figure 1).
These observations are consistent with the immunoﬂuoresence
analysis shown in Figure 2, where DTF inhibited IL-1β-induced
NF-κB nuclear translocation following exposure to IL-1 and DTF
for 4/20, 8/16, 12/12, 16/8 h of DTF/REST while 20/4 or 24/0h of
DTF/REST did not block NF-κB nuclear translocation completely.
(3) Anti-inﬂammatory effects of DTF are mediated by increased
Figure 1. DTF inhibits IL-1b induced NF-kB phosphorylation.
Figure 2. DTF inhibits IL-1b induced NF-kB nuclear translocation and synthesis.
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expression and synthesis of NF-κB inhibitors, IκBα and I-κB-β.
(4) DTF downregulates IL-1β-induced IκB kinase (IKK) activation
in cells treated with DTF/rest for 4/20, 8/16, 12/12, and 16/8.
Conclusions: This is the ﬁrst study to demonstrate persistent
effects of biomechanical signals in the surrounding proinﬂamma-
tory environment. Furthermore, biomechanical signals suppress
NF-kB signaling cascade. These signals act in two ways: (i) in-
hibit mRNA expression and synthesis of NF-κB, I-κBα and I-κBβ,
and (ii) downregulate IKKb activation and thus I-κB degradation.
The studies show the necessity of using adequate time intervals
of physical therapies for the optimal management of arthritic
joints.
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ACTIVIN A IS AN ANTI-CATABOLIC CYTOKINE
PRODUCED BY INJURED CARTILAGE VIA RELEASE OF
FIBROBLAST GROWTH FACTOR-2 AND ACTIVATION OF
NUCLEAR FACTOR KAPPA B
F. Watt1, S. Alexander1, Y. Sawaji1, M. Hermansson2,
J. Saklatvala1
1Kennedy Institute of Rheumatology, Imperial College, London,
United Kingdom; 2Karolinsksa Institute, Stockholm, Sweden
Purpose: Direct or indirect injuries to articular cartilage predis-
pose to osteoarthritis. We have previously shown that injury to
cartilage such as simple dissection causes the release of FGF-2
from a pericellular pool and activation of inﬂammatory signalling
pathways such as the mitogen activated protein kinases and
NFκB. Following such injury, the TGF β family member activin
A is synthesised by human articular cartilage. We investigated
a) how injury regulates the production of activin A by articular
cartilage and b) whether this molecule has an important function
in cartilage. Because TGF β has anti-inﬂammatory actions, the
effect of activin A on IL-1-induced breakdown of the proteoglycan
aggrecan in cartilage was assessed.
Methods: Activin A production was measured by ELISA of
porcine or human cartilage explant culture medium. mRNA in-
duction in cartilage explants or primary chondrocyte monolayers
was by RT-PCR for genes of interest. The effect of exogenous
activin A on IL-1 induced cleavage of aggrecan was determined
by western blotting medium from human cartilage explant culture
for the aggrecan cleavage neoepitope ARGSV.
Results: Activin A mRNA and protein were induced by sim-
ple dissection of human or porcine cartilage from the articular
surface. Its production was due to an active cellular process.
Activin A mRNA in cartilage explants was induced by FGF-2.
Activin A production following injury was reduced by 80% by the
FGF receptor inhibitor PD173074 and 70% by the IKK inhibitor
BMS345541. FGF appeared to induce activin A production via
ERK and src family kinases. Low concentrations of exogenous
activin A suppressed the IL-1 induced aggrecanase-mediated
cleavage of aggrecan in human articular cartilage. Osteoarthritic
cartilage was noted to produce signiﬁcantly more activin A than
normal cartilage.
Conclusions:Activin A is produced by chondrocytes in response
to injury of articular cartilage in an FGF and NFκB-dependent
manner. This molecule appears to be anti-catabolic for carti-
Abstract 160 – Table 1
Day 5 Day 9 Day 13
GAGs (µg)/DNA (µg) GAGs (µg)/DNA (µg) GAGs (µg)/DNA (µg)
(n) (n) (n)
Non-Obese Group (BMI < 30 kg/m2) 31.8 (3) 53.3 (6) 34.9 (2)
Obese Group (BMI > 30 kg/m2) 140.6 (6) 205.6 (6) 323.8 (3)
lage by preventing aggrecan breakdown, and its production is
enhanced in osteoarthritic tissue. Activin A may therefore be an
endogenous chondroprotective cytokine, whose actions might be
exploited therapeutically.
160
METABOLIC ACTIVITY IN OSTEOARTHRITIC KNEES
CORRELATES WITH BODY MASS INDEX
M.C. Niesen1, E.B. Gausden2, A.L. Buchholz1, H.F. Stampﬂi2,
M.W. Squire2, M.G. Wisniewski2, C. Dufour2, D.R. VerBunker2,
A. Munoz2, L.D. Kaplan2
1School of Medicine and Public Health, University of
Wisconsin-Madison, Madison, WI; 2Division of Sports Medicine,
Department of Orthopedics and Rehabilitation, University of
Wisconsin Hospital and Clinics, Madison, WI
Purpose: Osteoarthritis (OA) is the most common form of arthri-
tis in the United States and has been linked to obesity. It is
hypothesized that obesity, deﬁned as a body mass index (BMI)
over 30 kg/m2, increases the incidence of OA through increased
joint pressure and disruption of normal metabolism. Studies have
identiﬁed factors in obese patients that may function as regula-
tors of chondrocyte metabolism. However, metabolic changes
resulting from obesity that may precede OA have not been thor-
oughly investigated. The purpose of this study was to identify
the relationship between chondrocyte metabolism and BMI in
osteoarthritic tissue.
Methods: Grade 0 or 1 cartilage was removed from the me-
dial and/or lateral femoral condyles after total knee arthroplasty
and was digested in collagenase. The chondrocytes were then
resuspended in alginate beads at 2x106 cells/mL. The beads
were equilibrated in media containing 10% fetal bovine serum
for 7 days (37°C) and then separated into wells (8 beads/well)
with 1 mL media. Media was replaced every 48 hours. At day
5, 9, and 13, beads were dissolved in 55 mM sodium citrate
and centrifuged into their cell matrix and alginate portions. Gly-
cosaminoglycan (GAG) content was measured in the cell pellet,
alginate, and saved media using the dimethylmethylene blue
(DMMB) assay. The DMMB results were normalized to DNA con-
tent. To assess differences in GAG content between obese and
non-obese group, a Wilcoxon rank sum test was used. P < 0.05
was used as the criterion for signiﬁcance. All procedures were
approved by the University of Wisconsin - Madison, Institutional
Review Board.
Results: At day 5, the average normalized GAGs from the obese
group (BMI >30 kg/m2) was >4-fold higher than the average
normalized GAGs in the non-obese group (BMI <30 kg/m2).
Table 1 displays the normalized GAG averages from the 3 study
days.
Fig. 1 shows a signiﬁcant and linear relationship between BMI
and normalized GAGs at day 9 (p=0.0003).
The 4-fold difference in normalized GAGs between obese
and non-obese groups continued at day 9 with signiﬁcance
(p=0.0087) and widened at day 13, without signiﬁcance. Fig. 2
displays the day 9 averages of normalized GAG content from the
obese and non-obese groups.
Some osteoarthritic knees had less tissue quality, therefore GAG
testing was limited to earlier study days resulting in variable
sample numbers for each study day.
